LYFAX Mutual Fund

LYFAX Mutual Fund

NAV$17.25
See how much of LYFAX you already own
Just $25 once·$99/mo·Download sample
X-ray my portfolio free

Fund Essentials - as of Jun 30, 2026

Net Assets
$5M
Expense Ratio
1.66%
Dividend Yield (Current)
1.19%
Holdings
62
Inception Date
Nov 29, 2019
Fund Family
Alpha Centric Fund
Investment Style
PRO
Asset Class
PRO
Legal Structure
PRO
Dividend Frequency
Annually

Performance

YTD+20.19%
1 Year+49.75%
3 Year+13.29%
5 Year+8.32%

Asset Allocation

Stocks: 95.75%
Cash: 4.25%
See how much of LYFAX you already own
Your funds unpacked, overlap, fees and score, free on screen. The full report comes with FundXLS. Download sample.
X-ray my portfolio free

Top Holdings

View All →
TickerNameWeight
GILDGilead Sciences5.53%
VRTXNvaesrtex Pharmaceuticals Inc5.33%
AZN:LNAstrazeneca Plc4.63%
FXFXXFirst Am Treas Obli-X4.26%
ROIV:BMRoivant Sciences Ltd. Common Shares3.67%
Top 10 Concentration: 40.74%Report Date: Jun 30, 2026
Download all 62 holdings for LYFAX
CSV export with sector, industry & share changes
Get CSV

Dividend Summary

View Details →
Dividend Yield (Current)
1.19%
Frequency
Annually
Latest Distribution
$1.65
-

Peer Comparison

Benchmark
PRO
Peer outperformance: PRO
Category rank: PRO
This Mutual Fund
PRO
Peer Avg
PRO

LYFAX Mutual Fund Overview

LYFAX Mutual Fund (AlphaCentric Life Sciences and Healthcare Fund Class A) is managed by Alpha Centric Fund with $4.9M in net assets. LYFAX expense ratio is 1.66%, holding 62 positions across sectors including Health Care, Financials. Inception date: 2019-11-29.

LYFAX performance shows a YTD return of 20.19%. The 1-year return is 49.75% and the 5-year return is 8.32%. LYFAX dividend yield stands at 1.19%, paid annually.

LYFAX top holdings include Gilead Sciences (5.5%), Nvaesrtex Pharmaceuticals Inc (5.3%), Astrazeneca Plc (4.6%), First Am Treas Obli-X (4.3%), Roivant Sciences Ltd. Common Shares (3.7%). Go to all LYFAX holdings, LYFAX sectors, or LYFAX dividends.

LYFAX can be compared against other funds. Use LYFAX overlap to find shared positions, or LYFAX vs another fund for a side-by-side view. LYFAX alternatives are available via the screener, along with tax-loss harvesting opportunities.